Reconstitution of Impaired Autologous Mixed Lymphocyte Reactivity in Rheumatoid Arthritis

References

• Decker J L, Malone D G, Haroqui B, Wahl S, Schrieber L, Klippel, et al. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment. Annals Int Med. 1984; 101: 810–24
   PubMed Web of Science ®Google Scholar
• Padula S J, Clerk R B, Korn J H. Cell mediated immunity in rheumatic disease. Human Pathol. 1986; 17: 254–63
   PubMed Web of Science ®Google Scholar
• Pope R M, Talal N. Autoimmunity in rheumatoid arthritis. Concepts Immunopathol. 1985; 1: 219–50
   PubMedGoogle Scholar
• Opelz G, Kuichi M, Takasugi M, Terasaki P. Autologous stimulation of human lymphocyte suhpopulations. J Exp Med. 1975; 142: 1327–33
   PubMed Web of Science ®Google Scholar
• Kuntz M, Innes J, Weksler M. Lymphocyte transformation induced by autologous cells: I. V. Human T‐lymphocyte proliferation induced by autologous or allogeneic non‐T‐lymphocytes. J Exp Med. 1976; 143: 1042–54
   PubMed Web of Science ®Google Scholar
• Palacios R, Molter G. HLA‐DR antigens render resting T‐ cells sensitive to interleukin‐2 and induce production of the growth factor in the autologous mixed lymphocyte reaction. Cell Immunol. 1981; 63: 143–53
   PubMed Web of Science ®Google Scholar
• Lattime E, Gillis S, Pecoraro G, Stutman O. Ia‐dependent interleukin‐2 production in synergeic cellular interactions. J Immunol. 1982; 128: 480–5
   PubMed Web of Science ®Google Scholar
• Smith J B, Knowlton R P. Activation of suppressor T‐cells in human autologous mixed lymphocyte culture. J Immunol. 1979; 123: 419–22
   PubMed Web of Science ®Google Scholar
• Wolos J A, Smith J B. Helper cells in the autologous mixed lymphocyte reaction, III. Production of helper factors (2) distinct from interleukin‐2. J Exp Med. 1982; 156: 1807–20
   PubMed Web of Science ®Google Scholar
• Yu D T Y, Chinrazzi N, Kunkel H G. Helper factors derived from autologous mixed lymph cultures. Cell Immunol. 1980; 50: 305–13
   PubMed Web of Science ®Google Scholar
• Smolen J S, Luger T A, Chused T M, Steinherg A D. Responder cells in the human autologous mixed lymphocyte reaction. J Clin Invest. 1981; 68: 1601–4
   PubMed Web of Science ®Google Scholar
• Romain P L, Morimoto C, Daley J F, Palley L S, Reinherz E L, Schlossman S F. Reactivity of inducer cell subsets and T8‐cell activation during the human autologous mixed lymphocyte reaction. Clin Immunol Immunopathol. 1984; 39: 117–28
   Google Scholar
• Morimoto C, Romain P L, Fox D A, Anderson P, Dimaggio M, Levine H, Schlossman S F. Abnormalities CD4+ T‐lymphocyte subsets in inflammatory rheumatic diseases. Am J Med. 1988; 84: 817–25
   PubMed Web of Science ®Google Scholar
• Keystone E C, Poplonski L, Snow K M, Martell M. Impaircd AMLR reactivity of peripheral blood T‐cells subsets in rheumatoid arthritis. Clin Exp Immunol. 1989; 78: 184–188
   PubMed Web of Science ®Google Scholar
• Pope R, McChesney L, Talal N, Fischbach M. Characterization of the defective autologous mixed lymphocyte response in rheumatoid arthritis. Arthritis Rheum. 1987; 27: 1234–43
   Google Scholar
• Panayi G S, Mills M. Second‐line drug treatment in rheumatoid arthritis associated with depressed autologous niixed lymphocyte reaction. Rheumatol Int. 1986; 6: 25–9
   PubMed Web of Science ®Google Scholar
• Ropes M W, Bennett G A, Cobb S, Jacox R, Jessar K A. 1958 revised diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958; 9: 175–6
   PubMedGoogle Scholar
• Boyum A. Isolation of mononuclear cells and granulocytes from human blood. J Clin Lab Invest. 1956; 21(suppl 97)71–84
   Google Scholar
• Keystone E C, Jaglal S, Shore A. Interleukin 1 and interlcukin 2 generation by peripheral blood cells from patients with ankylosing spondylitis. J Rheumatol. 1986; 13: 944–7
   PubMed Web of Science ®Google Scholar
• Jorgan G. Basis for the probit analysis of an intcrferon plaque reduction assay. J Gen Virol. 1972; 14: 49–55
   PubMed Web of Science ®Google Scholar
• Gilles S, Feum M M, Ou W, Smith K A. T‐cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol. 1978; 120: 2027–32
   PubMed Web of Science ®Google Scholar
• Wang A, Lu S D, Mark D F. Site specific mutagenesis of the human interleukin‐2 gene: structure‐function analysis of the cysteine residues. Sciences 1984; 224: 1431–3
   PubMed Web of Science ®Google Scholar
• Rosenberg S A, Gwim E A, McGrogan M, Doyle M, Kawasaki E, Koths K, Mark D F. Biologicdl activity of recombinant human interleukin‐2 produced in. Escherichia coli. Science. 1984; 223: 1412–5
   Google Scholar
• Djeu Y, Kashara T, Balow J, Tsokos G. Decreased interleukin 2 inhibitor in sera of patients with autoimmune disorders. Clin Exp Immunol. 1986; 65: 279–85
   PubMed Web of Science ®Google Scholar
• Miossec P, Kashiwado T, Ziff M. Inhibitor of interleukin 2 in rheumatoid synovial fluid. Arthritis Rheum. 1987; 30: 121–29
   PubMed Web of Science ®Google Scholar
• Nouri A, Panayi G S. Cytokines and the chronic inflammation of rheumatic disease. III. Deficient interleukin‐2 production in rheumatoid arthritis is not due to suppressor mechanisms. J Rheumatol. 1987; 14: 902–6
   PubMed Web of Science ®Google Scholar
• Kita G D, Salmon M, Allan I M, Bacon P A. The T‐cell system in rheumatoid arthritis: Activated or defective. Scand J Rheumatol. 1988; 76: 161–73
   Google Scholar
• Smith K A. The biomolecular structure of the interleukin 2 receptor. Immunology Today. 1988; 9: 36–7
   PubMedGoogle Scholar
• Sharon S, Klausner R D, Cullen B R. Novel interleukin‐2 receptor subunit detected by cross‐linking under high‐atfinity conditions. Science 1986; 234: 859–63, (Issue 4778, Nov. 14, 1986)
   PubMed Web of Science ®Google Scholar
• Emery P, Wood N, Gentry K, Stockman A, Mackay I R, Bernard O. High affinity. Interleukin 2 receptors on blood lymphocytes are decreased during active rheumatoid arthritis. Arthritis Rheum. 1988; 31: 1176–81
   PubMedGoogle Scholar
• Fox R I, Fong S, Sabharwal N, Carstens S A, Kung P C, Vaughn J H. Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. J Immunol. 1982; 128: 351–4
   PubMed Web of Science ®Google Scholar
• Burmester G R, John B, Gramatzki M, Zacker J, Kalden J R. Activated T cells in vivo and in vitro: Divergence in expression of Tac and la antigens in the non‐blastoid small T‐cells of inflammation and normal T‐cells activated. in vitro. J Immnol. 1984; 133: 1230–4
   PubMed Web of Science ®Google Scholar